| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.47 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.095 | 0.09 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |